Filing Manager
HARBOURVEST PARTNERS LLC
Reporting Manager
HarbourVest Partners L.P.
Symbol
CAMP
Shares outstanding
47,109,185 shares
Disclosed Ownership
1,271,948 shares
Ownership
2.7%
Form type
SCHEDULE 13G/A
Filing time
01 Oct 2025, 11:30:54 UTC
Date of event
30 Sep 2025
Previous filing
14 May 2025

Quoteable Key Fact

"HARBOURVEST PARTNERS LLC disclosed 2.7% ownership in CAMP4 Therapeutics Corporation Common Stock, par value $0.0001 per share (CAMP) on 30 Sep 2025."

Quick Takeaways

  • HARBOURVEST PARTNERS LLC filed SCHEDULE 13G/A for CAMP4 Therapeutics Corporation Common Stock, par value $0.0001 per share (CAMP).
  • Disclosed ownership: 2.7%.
  • Date of event: 30 Sep 2025.

What Changed

  • Previous schedule filing date: 14 May 2025.
  • Current filing was accepted on 01 Oct 2025, 11:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
HarbourVest Partners L.P. 2.7% 1,271,948 0 1,271,948 By: HarbourVest Partners, LLC, its General Partner; /s/ Adam Freedman Adam Freedman; Chief Compliance Officer
HarbourVest Partners, LLC 2.7% 1,271,948 0 1,271,948 /s/ Adam Freedman Adam Freedman; Chief Compliance Officer
SMRS-TOPE LLC 2.7% 1,271,948 1,271,948 0 By: HVST-TOPE LLC, its Managing Member; HarbourVest Partners L.P., its Manager; HarbourVest Partners, LLC, its General Partner; /s/ Adam Freedman Adam Freedman; Chief Compliance Officer
HVST-TOPE LLC 2.7% 1,271,948 0 1,271,948 By: HarbourVest Partners L.P., its Manager; HarbourVest Partners, LLC, its General Partner; /s/ Adam Freedman Adam Freedman; Chief Compliance Officer